<section xmlns="http://xml.house.gov/schemas/uslm/1.0" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" style="-uslm-lc:I80" id="id14836775-3a70-11f1-b089-c1e1e512a22d" identifier="/us/usc/t21/s399j"><num value="399j">§ 399j.</num><heading> Abraham Accords Office</heading><subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="id14836776-3a70-11f1-b089-c1e1e512a22d" identifier="/us/usc/t21/s399j/a"><num value="a" class="bold">(a)</num><heading class="bold"> In general</heading><content><p style="-uslm-lc:I11" class="indent0">The Secretary, acting through the Commissioner of Food and Drugs, shall establish within the Food and Drug Administration an office, to be known as the Abraham Accords Office, to be headed by a director.</p>
</content>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="id14836777-3a70-11f1-b089-c1e1e512a22d" identifier="/us/usc/t21/s399j/b"><num value="b" class="bold">(b)</num><heading class="bold"> Office</heading><chapeau style="-uslm-lc:I11" class="indent0">Not later than 2 years after <date date="2026-02-03">February 3, 2026</date>, the Secretary shall—</chapeau><paragraph style="-uslm-lc:I12" class="indent1" id="id14836778-3a70-11f1-b089-c1e1e512a22d" identifier="/us/usc/t21/s399j/b/1"><num value="1">(1)</num><chapeau> in consultation with the governments of Abraham Accords countries, as well as appropriate United States Government diplomatic and security personnel—</chapeau><subparagraph style="-uslm-lc:I13" class="indent2" id="id14836779-3a70-11f1-b089-c1e1e512a22d" identifier="/us/usc/t21/s399j/b/1/A"><num value="A">(A)</num><content> select the location of the Abraham Accords Office in an Abraham Accords country; and</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="id1483677a-3a70-11f1-b089-c1e1e512a22d" identifier="/us/usc/t21/s399j/b/1/B"><num value="B">(B)</num><content> establish such office; and</content>
</subparagraph>
</paragraph>
<paragraph style="-uslm-lc:I12" class="indent1" id="id1483677b-3a70-11f1-b089-c1e1e512a22d" identifier="/us/usc/t21/s399j/b/2"><num value="2">(2)</num><content> assign to such office such personnel of the Food and Drug Administration as the Secretary determines necessary to carry out the functions of such office.</content>
</paragraph>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="id1483677c-3a70-11f1-b089-c1e1e512a22d" identifier="/us/usc/t21/s399j/c"><num value="c" class="bold">(c)</num><heading class="bold"> Duties</heading><chapeau style="-uslm-lc:I11" class="indent0">The Secretary, acting through the Director of the Abraham Accords Office, shall—</chapeau><paragraph style="-uslm-lc:I12" class="indent1" id="id1483677d-3a70-11f1-b089-c1e1e512a22d" identifier="/us/usc/t21/s399j/c/1"><num value="1">(1)</num><chapeau> after the Abraham Accords Office is established—</chapeau><subparagraph style="-uslm-lc:I13" class="indent2" id="id1483677e-3a70-11f1-b089-c1e1e512a22d" identifier="/us/usc/t21/s399j/c/1/A"><num value="A">(A)</num><content> as part of the Food and Drug Administration’s work to strengthen the international oversight of regulated commodities, provide technical assistance to regulatory partners in Abraham Accords countries on strengthening regulatory oversight and converging regulatory requirements for the oversight of regulated products, including good manufacturing practices and other issues relevant to manufacturing medical products that are regulated by the Food and Drug Administration; and</content>
</subparagraph>
<subparagraph style="-uslm-lc:I13" class="indent2" id="id1483677f-3a70-11f1-b089-c1e1e512a22d" identifier="/us/usc/t21/s399j/c/1/B"><num value="B">(B)</num><content> facilitate interactions between the Food and Drug Administration and interested parties in Abraham Accords countries, including by sharing relevant information regarding United States regulatory pathways with such parties, and facilitate feedback on the research, development, and manufacturing of products regulated in accordance with this chapter; and</content>
</subparagraph>
</paragraph>
<paragraph style="-uslm-lc:I12" class="indent1" id="id14836780-3a70-11f1-b089-c1e1e512a22d" identifier="/us/usc/t21/s399j/c/2"><num value="2">(2)</num><content> carry out other functions and activities as the Secretary determines to be necessary to carry out this section.</content>
</paragraph>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="id14836781-3a70-11f1-b089-c1e1e512a22d" identifier="/us/usc/t21/s399j/d"><num value="d" class="bold">(d)</num><heading class="bold"> Abraham Accords country defined</heading><content><p style="-uslm-lc:I11" class="indent0">In this section, the term “Abraham Accords country” means a country identified by the Department of State as having signed the Abraham Accords Declaration.</p>
</content>
</subsection>
<subsection style="-uslm-lc:I19" class="indent2 firstIndent-2" id="id14836782-3a70-11f1-b089-c1e1e512a22d" identifier="/us/usc/t21/s399j/e"><num value="e" class="bold">(e)</num><heading class="bold"> National security</heading><content><p style="-uslm-lc:I11" class="indent0">Nothing in this section shall be construed to require any action inconsistent with a national security recommendation provided by the Federal Government.</p>
</content>
</subsection>
<sourceCredit id="id14836783-3a70-11f1-b089-c1e1e512a22d">(<ref href="/us/act/1938-06-25/ch675/s1015">June 25, 1938, ch. 675, § 1015</ref>, as added <ref href="/us/pl/119/75/dJ/tVI/s6611/a">Pub. L. 119–75, div. J, title VI, § 6611(a)</ref>, <date date="2026-02-03">Feb. 3, 2026</date>, <ref href="/us/stat/140/701">140 Stat. 701</ref>.)</sourceCredit>
<notes type="uscNote" id="id14836784-3a70-11f1-b089-c1e1e512a22d">
<note style="-uslm-lc:I74" role="crossHeading" topic="editorialNotes" id="id14836785-3a70-11f1-b089-c1e1e512a22d"><heading class="centered"><b>Editorial Notes</b></heading></note>
</notes>
</section>